Georgia Moschopoulou

Dr. Georgia Moschopoulou

School of Applied Biology and Biotechnology, Agricultural University of Athens, 11855 Athens, Greece
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2020 in Sensors
Verified
Journal Article
Open access
PDF file
Sofia MavrikouSofia Mavrikou
Sofia Mavrikou
GMGeorgia Moschopoulou
Georgia Moschopoulou
VTVasileios Tsekouras
Vasileios Tsekouras
Spyridon KintziosSpyridon Kintzios
Spyridon Kintzios
One of the key challenges of the recent COVID-19 pandemic is the ability to accurately estimate the number of infected individuals, particularly asymptomatic and/or early-stage patients. We herewith report the proof-of-concept development of a biosensor able to detect the SARS-CoV-2 S1 spike protein expressed on the surface of the virus. The biosensor is based on membrane-engineered mammalian cells bearing the human chimeric spike S1 antibody. We demonstrate that the attachment of the protein to the membrane-bound antibodies resulted in a selective and considerable change in the cellular bioelectric properties measured by means of a Bioelectric Recognition Assay. The novel biosensor provided results in an ultra-rapid manner (3 min), with a detection limit of 1 fg/mL and a semi-linear range of response between 10 fg and 1 μg/mL. In addition, no cross-reactivity was observed against the SARS-CoV-2 nucleocapsid protein. Furthermore, the biosensor was configured as a ready-to-use platform, including a portable read-out device operated via smartphone/tablet. In this way, we demonstrate that the novel biosensor can be potentially applied for the mass screening of SARS-CoV-2 surface antigens without prior sample processing, therefore offering a possible solution for the timely monitoring and eventual control of the global coronavirus pandemic.


1 December 2008 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
GMGeorgia Moschopoulou
Georgia Moschopoulou
KVKaterina Vitsa
Katerina Vitsa
FBFrederic Bem
Frederic Bem
NVNikos Vassilakos
Nikos Vassilakos
APAntonis Perdikaris
Antonis Perdikaris
SKSpiridon Kintzios
Spiridon Kintzios

8 November 2018 in Sensors
Verified
Journal Article
Open access
PDF file
Sofia MavrikouSofia Mavrikou
Sofia Mavrikou
GMGeorgia Moschopoulou
Georgia Moschopoulou
AZAthanasios Zafeirakis
Athanasios Zafeirakis
KKKonstantina Kalogeropoulou
Konstantina Kalogeropoulou
GGGeorgios Giannakos
Georgios Giannakos
Spyridon KintziosSpyridon Kintzios
Spyridon Kintzios
Prostate-specific antigen (PSA) is the established routine screening tool for the detection of early-stage prostate cancer. Given the laboratory-centric nature of the process, the development of a portable, ultra rapid high-throughput system for PSA screening is highly desirable. In this study, an advancedpoint-of-care system for PSA detection in human serum was developed based on a cellular biosensor where the cell membrane was modified by electroinserting a specific antibody against PSA. Thirty nine human serum samples were used for validation of this biosensory system for PSA detection. Samples were analyzed in parallel with a standard immunoradiometric assay (IRMA) and an established electrochemical immunoassay was used for comparison purposes. They were classified in three different PSA concentration ranges (0, <4 and ≥4 ng/mL). Cells membrane-engineered with 0.25 μg/mL anti-PSA antibody demonstrated a statistically lower response against the upper (≥4 ng/mL) PSA concentration range. In addition, the cell-based biosensor performed better than the immunosensor in terms of sensitivity and resolution against positive samples containing <4 ng/mL PSA. In spite of its preliminary, proof-of-concept stage of development, the cell-based biosensor could be used as aninitiative for the development of a fast, low-cost, and high-throughput POC screening system for PSA.

23 April 2008 in Sensors
Verified
Journal Article
Open access
PDF file
Sofia MavrikouSofia Mavrikou
Sofia Mavrikou
KFKelly Flampouri
Kelly Flampouri
GMGeorgia Moschopoulou
Georgia Moschopoulou
OMOlga Mangana
Olga Mangana
AMAlexandros Michaelides
Alexandros Michaelides
Spyridon KintziosSpyridon Kintzios
Spyridon Kintzios
The conventional analysis of pesticide residues in analytical commodities, such as tobacco and tobacco products is a labor intensive procedure, since it is necessary to cover a wide range of different chemicals, using a single procedure. Standard analysis methods include extensive sample pretreatment (with solvent extraction and partitioning phases) and determination by GC and HPLC to achieve the necessary selectivity and sensitivity for the different classes of compounds under detection. As a consequence, current methods of analysis provide a limited sample capacity. In the present study, we report on the development of a novel cell biosensor for detecting organophosphate and carbamate pesticide residues in tobacco. The sensor is based on neuroblastoma N2a cells and the measurement of changes of the cell membrane potential, according to the working principle of the Bioelectric Recognition Assay (BERA). The presence of pesticide residues is detected by the degree of inhibition of acetylcholine esterase (AChE). The sensor instantly responded to both the organophoshate pesticide chlorpyriphos and the carbamate carbaryl in a concentration-dependent pattern, being able to detect one part per billion (1 ppb). Additionally, tobacco leaf samples (in blended dry form) were analyzed with both the novel biosensor and conventional methods, according to a double-blind protocol. Pesticide residues in tobacco samples caused a considerable cell membrane hyperpolarization to neuroblastoma cells immobilized in the sensor, as indicated by the increase of the negative sensor potential, which was clearly distinguishable from the sensor’s response against pesticide-free control samples. The observed response was quite reproducible, with an average variation of +5,6%. Fluorescence microscopy observations showed that treatment of the cells with either chlorpyrifos or carbaryl was associated with increased [Ca2+]cyt . The novel biosensor offers fresh perspectives for ultra-rapid, sensitive and low-cost monitoring of pesticide residues in tobacco as well as other food and agricultural commodities.

1 January 2015 in Chemosphere
Verified
Journal Article
Closed access
CZChristos Zikos
Christos Zikos
Alexandra EvangelouAlexandra Evangelou
Alexandra Evangelou
CKChrysoula-Evangelia Karachaliou
Chrysoula-Evangelia Karachaliou
GGGeorgia Gourma
Georgia Gourma
PBPetros Blouchos
Petros Blouchos
ELEvangelia Livaniou
Evangelia Livaniou